A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)
Clinical trial NCT04813926 · COMPLETED
Trial details
- NCT number
- NCT04813926
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-07-16
- Primary completion
- 2024-10-19
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.